IN THIS ISSUE

Managing Editor's Memo
Frank Diamond
Medication Management
Thomas Reinke

Is it a simple matter of pay for volume vs. pay for value, or is the situation far more complicated?

The Formulary Files
Krishna Rutvij Patel, PharmD
Tomorrow's Medicine
Thomas Morrow, MD

Medication is aimed at leptin deficiency, but clinical trials may be hard for managed care plans to evaluate properly

A blueprint for high-volume, high-quality lung cancer screening that is detecting cancer earlier—and helping to save lives

Clinical Brief

Multiple Sclerosis: New Perspectives on the Patient Journey–2019 Update
Summary of an Actuarial Analysis and Report